Kenneth A. Clark

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Sunnyvale, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Bhaskar Anand, as Attorney-in-Fact for Kenneth Clark
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Kenneth A. Clark

Form 4 holding Director

Summit Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
17,796
Estimated value
$155,892
Report date
02 Jan 2026
Price
$8.76
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Pulse Biosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
8,026
Estimated value
Report date
20 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kenneth A. Clark

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .